Markets

Health Care Sector Update for 12/22/2015: CBLI, PBMD

Top Health-care stocks:

JNJ: flat

PFE: +0.1%

ABT: flat

MRK: flat

AMGN: flat

Health-care shares were mainly unchanged in pre-market trade on Tuesday.

In health-care stocks news, Cleveland BioLabs ( CBLI ) said Tuesday that through a series of transactions and in cooperation with Russian venture fund Rusnano, it has recapitalized Panacela Labs, an anti-tumor joint venture currently being tested on patients with prostate cancer.

Shares in the company were unchanged at $3.84 pre-bell. The company has traded between $1.84 and $7.60 over the past 52 weeks.

And Prima BioMed ( PBMD ), an immuno-oncology developer, Tuesday reported the initiation of the first trial site in a phase IIb clinical study of its compound IMP321 for the treatment of metastatic breast cancer. The first patient is expected to be dosed in early 2016.

Shares in the company were 5.5% higher at $1.15 pre-bell. Over the past 52 weeks, the stock has traded between $0.42 and $6.48.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CBLI

Other Topics

Commodities

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More